Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "MitoEAGLE blood cells 1"

From Bioblast
Line 7: Line 7:
|journal=MitoEAGLE preprint
|journal=MitoEAGLE preprint
|abstract=::: '''Version beta 01'''
|abstract=::: '''Version beta 01'''
:::::# The evaluation of mitochondrial function remains crucial for the diagnosis of a spectrum of human pathologies. Peripheral blood provides an easily accessible source of primary human cells. However, mitochondrial respiratory studies in blood cells still require standardization. The procedures applied in bioenergetic assessments involve multiple steps in the pre-analytical, analytical and data analysis phase. The aim of this review is to summarize methods of preparing and applying peripheral blood mononuclear cells (PBMCs) and platelets (PLTs) for mitochondrial respiratory studies. For this purpose we report original data from several laboratories and literature data. Β 
:::::# The evaluation of mitochondrial function remains crucial for the diagnosis of a spectrum of human pathologies. Peripheral blood provides an easily accessible source of primary human cells. However, mitochondrial respiratory studies in blood cells still require standardization. The procedures applied in bioenergetic assessments involve multiple steps in the pre-analytical, analytical and data analysis phase. The aim of this review is to summarize methods of preparing and applying peripheral blood mononuclear cells (PBMC) and platelets (PLT) for mitochondrial respiratory studies. For this purpose we report original data from several laboratories and literature data. Β 
:::::# We do not present results on patients, but characterize healthy control groups. Exclusion criteria in the pre-analytical phase are related to smoking, alcohol intake, BMI, lifestyle interventions, and medications. In pathophysiological studies, subjects have to be matched with controls for sex, age and genetic background. Time of sampling, fasting and resting state require standardization.
:::::# We do not present results on patients, but characterize healthy control groups. Exclusion criteria in the pre-analytical phase are related to smoking, alcohol intake, BMI, lifestyle interventions, and medications. In pathophysiological studies, subjects have to be matched with controls for sex, age and genetic background. Time of sampling, fasting and resting state require standardization.
:::::# Anticoagulants are used for whole blood sampling (''e.g.'', K-EDTA, lithium heparin, sodium citrate). Protocols are optimized on the basis of yield, cell fraction purity and respiratory function. Β 
:::::# Anticoagulants are used for whole blood sampling (''e.g.'', K-EDTA, lithium heparin, sodium citrate). Protocols are optimized on the basis of yield, cell fraction purity and respiratory function. Β 
Line 15: Line 15:
:::::# Specific protocols are used for respiration assessments in intact and permeabilized. The type of medium used for respirometry (MiR05, RPMI, plasma) needs further evaluation.
:::::# Specific protocols are used for respiration assessments in intact and permeabilized. The type of medium used for respirometry (MiR05, RPMI, plasma) needs further evaluation.
:::::# Normalization is important to interpret and compare the results of respiratory studies. It should include data on contamination of PBMCs with PLTs, cell viability (''e.g.'', succinate test), flux control ratios, total protein concentration, citrate synthase activity. Some other markers, like clusters of differentiation specific for leukocytes and platelets can be taken into consideration.
:::::# Normalization is important to interpret and compare the results of respiratory studies. It should include data on contamination of PBMCs with PLTs, cell viability (''e.g.'', succinate test), flux control ratios, total protein concentration, citrate synthase activity. Some other markers, like clusters of differentiation specific for leukocytes and platelets can be taken into consideration.
:::::# Finally, we summarize emerging recommendations for mitochondrial respiratory studies in intact and permeabilized PBMCs and PLTs towards building a data base of healthy subjects that can be used as controls in clinical studies.
:::::# Finally, we summarize emerging recommendations for mitochondrial respiratory studies in intact and permeabilized PBMC and PLT towards building a data base of healthy subjects that can be used as controls in clinical studies.
}}
}}
{{Labeling
{{Labeling

Revision as of 10:33, 14 February 2018


MiPsociety
News and Events        
BEC 2020.1 Mitochondrial physiology
       
MitoEAGLE
        Working Groups         Short-Term Scientific Missions         Management Committee         Members        
MitoGlobal
   


EU-logo.jpg

COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


MitoEAGLE blood cells 1


Publications in the MiPMap
MitoEAGLE blood cells group 2018-01-29 An interlaboratory guide through procedures for mitochondrial respiratory studies with intact and permeabilized peripheral blood mononuclear cells and platelets.

Β» MitoEAGLE blood cells group (WG 4)

Calabria E, Chang SC, Duicu OM, Garcia-Souza LF, Gnaiger E, Labieniec-Watala M, Michalak S, Siewiera K, Silaidos C, Sumbalova Z, Volani C (2018) MitoEAGLE preprint

Abstract:

Version beta 01
  1. The evaluation of mitochondrial function remains crucial for the diagnosis of a spectrum of human pathologies. Peripheral blood provides an easily accessible source of primary human cells. However, mitochondrial respiratory studies in blood cells still require standardization. The procedures applied in bioenergetic assessments involve multiple steps in the pre-analytical, analytical and data analysis phase. The aim of this review is to summarize methods of preparing and applying peripheral blood mononuclear cells (PBMC) and platelets (PLT) for mitochondrial respiratory studies. For this purpose we report original data from several laboratories and literature data.
  2. We do not present results on patients, but characterize healthy control groups. Exclusion criteria in the pre-analytical phase are related to smoking, alcohol intake, BMI, lifestyle interventions, and medications. In pathophysiological studies, subjects have to be matched with controls for sex, age and genetic background. Time of sampling, fasting and resting state require standardization.
  3. Anticoagulants are used for whole blood sampling (e.g., K-EDTA, lithium heparin, sodium citrate). Protocols are optimized on the basis of yield, cell fraction purity and respiratory function.
  4. The time and temperature during transport and storage of whole blood has to be monitored carefully and evaluated in terms of final outcome. Characterization of whole blood provides rigorous exclusion criteria for controls.
  5. Separation procedures depend on the type of cells harvested for respirometric studies (PLT, PBMC, or both). Media, centrifugation conditions, cell counting and cell viability methods are evaluated. Results on purity of preparations (e.g., PLT contamination in PBMC fraction, purity of PLT fraction), recovery and yield of cells are compared in studies using a variety of cell separation methods.
  6. Information is lacking on the effect of storage and conditions during processing of isolated cell types before respirometry. Temperature, media, antibiotics, proteinase inhibitors cocktail, density of cells during storage, tilting of cell fraction might significantly affect the measurements.
  7. Specific protocols are used for respiration assessments in intact and permeabilized. The type of medium used for respirometry (MiR05, RPMI, plasma) needs further evaluation.
  8. Normalization is important to interpret and compare the results of respiratory studies. It should include data on contamination of PBMCs with PLTs, cell viability (e.g., succinate test), flux control ratios, total protein concentration, citrate synthase activity. Some other markers, like clusters of differentiation specific for leukocytes and platelets can be taken into consideration.
  9. Finally, we summarize emerging recommendations for mitochondrial respiratory studies in intact and permeabilized PBMC and PLT towards building a data base of healthy subjects that can be used as controls in clinical studies.


Labels: MiParea: Respiration, Instruments;methods, mtDNA;mt-genetics, nDNA;cell genetics, Gender  Pathology: Aging;senescence 

Organism: Human  Tissue;cell: Blood cells, Platelet  Preparation: Intact cells, Permeabilized cells  Enzyme: Marker enzyme 

Coupling state: LEAK, ROUTINE, OXPHOS, ET  Pathway: F, N, S, Gp, CIV, NS, Other combinations, ROX 



Co-authors: The present alphabetical list of co-authors icludes all actively involved participants of MitoEAGLE Innsbruck 2018 and will be extended by further contributors at MitoEAGLE Poznan 2018 and by MitoEAGLE members submitting their valuable contributions. All co-authors will have to confirm to have made a contribution and to have read the final manuscript.


File:Workflow.png
Fig. 1. Workflow and topics

Work in progress - Innsbruck retreat for preparation of MitoEAGLE Poznan 2018